Tissue Engineering of Craniofacial Structure

[1]  H. Losken,et al.  Rescue of coronal suture fusion using transforming growth factor-beta 3 (Tgf-beta 3) in rabbits with delayed-onset craniosynostosis. , 2003, The anatomical record. Part A, Discoveries in molecular, cellular, and evolutionary biology.

[2]  S. Bidic,et al.  Rabbit Calvarial Wound Healing by Means of Seeded Caprotite® Scaffolds , 2003, Journal of dental research.

[3]  V. Schramm,et al.  Resorbable Internal Fixation in Pediatric Cranial Base Surgery , 2002, The Laryngoscope.

[4]  H. Schliephake.  Bone growth factors in maxillofacial skeletal reconstruction , 2002 .

[5]  A. Moursi,et al.  Fibroblast growth factor 2 induces increased calvarial osteoblast proliferation and cranial suture fusion. , 2002, The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association.

[6]  J. Wozney.  Overview of Bone Morphogenetic Proteins , 2002, Spine.

[7]  Cory Berkland,et al.  Precise control of PLG microsphere size provides enhanced control of drug release rate. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[8]  K. C. Tan,et al.  [Individually CAD-CAM technique designed, bioresorbable 3-dimensional polycaprolactone framework for experimental reconstruction of craniofacial defects in the pig]. , 2002, Mund-, Kiefer- und Gesichtschirurgie : MKG.

[9]  Scott P Bartlett,et al.  Applications of a New Carbonated Calcium Phosphate Bone Cement: Early Experience in Pediatric and Adult Craniofacial Reconstruction , 2002, Plastic and reconstructive surgery.

[10]  Mark P. Mooney,et al.  Understanding Craniofacial Anomalies , 2002 .

[11]  R. Gassner,et al.  Effects of fixation type and guided tissue regeneration on maxillary osteotomy healing in rabbits. , 2002, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[12]  Y. Lanir,et al.  Enhancement of bone defect healing in old rats by TGF-β and IGF-1 , 2002, Experimental Gerontology.

[13]  W. Mark Saltzman,et al.  Building drug delivery into tissue engineering design , 2002, Nature Reviews Drug Discovery.

[14]  Yasuhiro Okazaki,et al.  Tissue-Engineered Bone Using Mesenchymal Stem Cells and a Biodegradable Scaffold , 2002, The Journal of craniofacial surgery.

[15]  H F Sailer,et al.  Slow and continuous application of human recombinant bone morphogenetic protein via biodegradable poly(lactide-co-glycolide) foamspheres. , 2002, International journal of oral and maxillofacial surgery.

[16]  K. Marra,et al.  Surface studies of coated polymer microspheres and protein release from tissue-engineered scaffolds , 2002, Journal of biomaterials science. Polymer edition.

[17]  J. de Dios Luna,et al.  The contribution of IGF‐I to skeletal integrity in postmenopausal women , 2001, Clinical endocrinology.

[18]  D. Mooney,et al.  Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.

[19]  L. Currie,et al.  The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. , 2001, Plastic and reconstructive surgery.

[20]  J. Goldstein.  The use of bioresorbable material in craniofacial surgery. , 2001, Clinics in plastic surgery.

[21]  N P Haas,et al.  Local application of growth factors (insulin-like growth factor-1 and transforming growth factor-beta1) from a biodegradable poly(D,L-lactide) coating of osteosynthetic implants accelerates fracture healing in rats. , 2001, Bone.

[22]  S. Frostick,et al.  Neurotrophin‐4 delivered by fibrin glue promotes peripheral nerve regeneration , 2001, Muscle & nerve.

[23]  M. Longaker,et al.  In vivo modulation of FGF biological activity alters cranial suture fate. , 2001, The American journal of pathology.

[24]  J O Hollinger,et al.  Controlled Release from Coated Polymer Microparticles Embedded in Tissue-engineered Scaffolds , 2001, Journal of drug targeting.

[25]  J. Heersche,et al.  Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone. , 2000, Bone.

[26]  J. Hubbell,et al.  Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[27]  A. Flyvbjerg,et al.  Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions , 2000, Experimental Gerontology.

[28]  C. Patrick,et al.  Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. , 2000, Journal of biomedical materials research.

[29]  P. Deluca,et al.  Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[30]  S. Feng,et al.  Nanospheres of biodegradable polymers: a system for clinical administration of an anticancer drug paclitaxel (Taxol). , 2000, Annals of the Academy of Medicine, Singapore.

[31]  Y. Ikada,et al.  Promoted bone healing at a rabbit skull gap between autologous bone fragment and the surrounding intact bone with biodegradable microspheres containing transforming growth factor-beta1. , 2000, Tissue engineering.

[32]  D. Sato,et al.  Bone augmentation by onlay implant using recombinant human BMP-2 and collagen on adult rat skull without periosteum. , 2000, Clinical oral implants research.

[33]  J L Cleland,et al.  Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[34]  A. Mikos,et al.  Effects of transforming growth factor β1 released from biodegradable polymer microparticles on marrow stromal osteoblasts cultured on poly(propylene fumarate) substrates , 2000 .

[35]  A. Mikos,et al.  Controlled release of transforming growth factor β1 from biodegradable polymer microparticles , 2000 .

[36]  G. Karsenty,et al.  The family of bone morphogenetic proteins. , 2000, Kidney international.

[37]  Antonios G. Mikos,et al.  Growth Factor Delivery for Tissue Engineering , 2000, Pharmaceutical Research.

[38]  D. Ornitz,et al.  Temporal and spatial gradients of Fgf8 and Fgf17 regulate proliferation and differentiation of midline cerebellar structures. , 2000, Development.

[39]  K. Chihara,et al.  Stimulatory Effect of Insulin‐Like Growth Factor Binding Protein‐5 on Mouse Osteoclast Formation and Osteoclastic Bone‐Resorbing Activity , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  S Jockenhoevel,et al.  Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[41]  M. Ito,et al.  Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. , 2000, The Journal of clinical investigation.

[42]  S. Giannini,et al.  Role of insulin-like growth factor-I in primary osteoporosis: A correlative study , 2000, Journal of endocrinological investigation.

[43]  R. Rizzoli,et al.  Protein Undernutrition‐Induced Bone Loss Is Associated with Decreased IGF‐I Levels and Estrogen Deficiency , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[44]  E. Mathiowitz,et al.  Nanosphere based oral insulin delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[45]  D J Mooney,et al.  Bioabsorbable polymer scaffolds for tissue engineering capable of sustained growth factor delivery. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[46]  M. Shameem,et al.  Extended release peptide delivery systems through the use of PLGA microsphere combinations , 2000, Journal of biomaterials science. Polymer edition.

[47]  P. Deluca,et al.  Enhancing Initial Release of Peptide from Poly(d,l-lactide-co-glycolide) (PLGA) Microspheres by Addition of a Porosigen and Increasing Drug Load , 2000, Pharmaceutical development and technology.

[48]  G. Verbeke,et al.  Down‐Regulation of the Serum Stimulatory Components of the Insulin‐like Growth Factor (IGF) System (IGF‐I, IGF‐II, IGF Binding Protein [BP]‐3, and IGFBP‐5) in Age‐Related (Type II) Femoral Neck Osteoporosis , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  Y. Ikada,et al.  Skull bone regeneration in primates in response to basic fibroblast growth factor. , 1999, Journal of neurosurgery.

[50]  J A Schrier,et al.  Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems. , 1999, Pharmaceutical development and technology.

[51]  K. Saleh,et al.  Osteoinductive growth factors in preclinical fracture and long bone defects models. , 1999, The Orthopedic clinics of North America.

[52]  Y. Capan,et al.  Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[53]  T Görner,et al.  Lidocaine loaded biodegradable nanospheres. II. Modelling of drug release. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[54]  J. Poser,et al.  Novel formulation of fibroblast growth factor‐2 in a hyaluronan gel accelerates fracture healing in nonhuman primates , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[55]  J O Hollinger,et al.  Tissue-engineered bone biomimetic to regenerate calvarial critical-sized defects in athymic rats. , 1999, Journal of biomedical materials research.

[56]  M. R. Aberturas,et al.  Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[57]  R. Ziegler,et al.  Age-related changes in insulin-like growth factor I and II in human femoral cortical bone: lack of correlation with bone mass. , 1999, Bone.

[58]  M. Morishita,et al.  Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. , 1999, Drug development and industrial pharmacy.

[59]  A. Tessler,et al.  Neurotrophic agents in fibrin glue mediate adult dorsal root regeneration into spinal cord. , 1999, Neurosurgery.

[60]  R. Gref,et al.  Lidocaine-loaded biodegradable nanospheres. I. Optimization Of the drug incorporation into the polymer matrix. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[61]  M. Lorenzoni,et al.  Guided bone regeneration with barrier membranes--a clinical and radiographic follow-up study after 24 months. , 1999, Clinical oral implants research.

[62]  J. Wozney,et al.  Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. , 1998, Journal of biomedical materials research.

[63]  S. W. Kim,et al.  Regulation of smooth muscle cell proliferation using paclitaxel-loaded poly(ethylene oxide)-poly(lactide/glycolide) nanospheres. , 1998, Journal of biomedical materials research.

[64]  S L Woo,et al.  The Effects of Platelet-Derived Growth Factor-BB on Healing of the Rabbit Medial Collateral Ligament , 1998, The American journal of sports medicine.

[65]  H. Tesluk,et al.  Effect of insulin-like growth factor type I on critical size calvarial bone defects in irradiated rats. , 1998, The Journal of craniofacial surgery.

[66]  M. Wells,et al.  Two lyophilized polymer matrix recombinant human bone morphogenetic protein-2 carriers in rabbit calvarial defects. , 1998, The Journal of craniofacial surgery.

[67]  J. Barnes,et al.  Effect of Locally Infused IGF‐I on Femoral Gene Expression and Bone Turnover Activity in Old Rats , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[68]  T. Wredmark,et al.  Insulin-like growth factor I increases bone formation in old or corticosteroid treated rats. , 1997, Acta orthopaedica Scandinavica.

[69]  Brooks M. Boyd,et al.  The Stability of Recombinant Human Growth Hormone in Poly(lactic-co-glycolic acid) (PLGA) Microspheres , 1997, Pharmaceutical Research.

[70]  B. Eppley,et al.  Degradation Characteristics of PLLA‐PGA Bone Fixation Devices , 1997, The Journal of craniofacial surgery.

[71]  M. Lind,et al.  Growth factors: possible new clinical tools. A review. , 1996, Acta orthopaedica Scandinavica.

[72]  E. Solheim,et al.  Guided tissue regeneration and local delivery of insulinlike growth factor I by bioerodible polyorthoester membranes in rat calvarial defects. , 1996, The International journal of oral & maxillofacial implants.

[73]  C. Kiritsy,et al.  Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. , 1996, Journal of periodontal research.

[74]  P. Boyne.  Animal studies of application of rhBMP-2 in maxillofacial reconstruction. , 1996, Bone.

[75]  R Langer,et al.  Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes , 1996, Biotechnology and bioengineering.

[76]  J. Wozney,et al.  Poly(α-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration , 1996 .

[77]  J. Hollinger,et al.  A Bone Regeneration Study: Transforming Growth Factor‐β1 and Its Delivery , 1996 .

[78]  M. Buckley,et al.  The Effects of Guided Tissue Regeneration and Fixation Technique on Osseous Wound Healing in Rabbit Zygomatic Arch Osteotomies , 1996, The Journal of craniofacial surgery.

[79]  R. Marcus,et al.  Effects of recombinant insulin‐like growth factor‐I and growth hormone on bone turnover in elderly women , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[80]  J. Hollinger,et al.  Delivery of Demineralized Bone Powder by Fibrin Sealant , 1995, Plastic and reconstructive surgery.

[81]  S. Mohan,et al.  An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone , 1995, Calcified Tissue International.

[82]  P. Speight,et al.  Effect of poly DL-lactide--co-glycolide implants and xenogeneic bone matrix-derived growth factors on calvarial bone repair in the rabbit. , 1994, Biomaterials.

[83]  J. Massagué,et al.  The TGF-β family and its composite receptors , 1994 .

[84]  C. R. Howlett,et al.  Effect of platelet-derived growth factor on tibial osteotomies in rabbits. , 1994, Bone.

[85]  J. Wozney,et al.  Transforming Growth Factor-β Gene Family Members and Bone* , 1994 .

[86]  J. Baker,et al.  Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r) , 1993, Cell.

[87]  A. Losken,et al.  Osseous guided tissue regeneration using a collagen barrier membrane. , 1993, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[88]  M. Urist,et al.  Osteoinductive Activity of Composites of Bone Morphogenetic Protein and Pure Titanium , 1993, Clinical orthopaedics and related research.

[89]  T. Tanaka,et al.  Morphological study of recombinant human transforming growth factor beta 1-induced intramembranous ossification in neonatal rat parietal bone. , 1993, Bone.

[90]  Mark E. Bolander,et al.  Regulation of Fracture Repair by Growth Factors , 1992, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[91]  E. Amento,et al.  Rapid publication TGF‐β1 induces bone closure of skull defects , 1991 .

[92]  M S Reddy,et al.  The effects of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. , 1991, Journal of periodontology.

[93]  H. Antoniades,et al.  A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. , 1989, Journal of clinical periodontology.

[94]  P. Aspenberg,et al.  Fibroblast growth factor stimulates bone formation. Bone induction studied in rats. , 1989, Acta orthopaedica Scandinavica.

[95]  M. Urist,et al.  Induction of callus formation by implants of bone morphogenetic protein and associated bone matrix noncollagenous proteins. , 1988, Clinical orthopaedics and related research.

[96]  J. Glowacki,et al.  APPLICATION OF THE BIOLOGICAL PRINCIPLE OF INDUCED OSTEOGENESIS FOR CRANIOFACIAL DEFECTS , 1981, The Lancet.

[97]  M. Urist,et al.  Bone: Formation by Autoinduction , 1965, Science.

[98]  Gary R. Grotendorst,et al.  Platelet-derived growth factor enhances demineralized bone matrix-induced cartilage and bone formation , 2007, Calcified Tissue International.

[99]  J. Mcvie,et al.  Polymer-coated albumin microspheres as carriers for intravascular tumour targeting of cisplatin , 2004, Cancer Chemotherapy and Pharmacology.

[100]  P. Marie,et al.  Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. , 2002, Histology and histopathology.

[101]  D. Rohner,et al.  Individuell mit CAD-CAM-Technik hergestellte, bioresorbierbare dreidimensionale Polycaprolaktongerüste zur experimentellen Rekonstruktion von kraniofazialen Defekten beim Schwein , 2002, Mund-, Kiefer- und Gesichtschirurgie.

[102]  J. Hubbell,et al.  Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. , 1999, Bioconjugate chemistry.

[103]  A. Pandit,et al.  Stimulation of angiogenesis by FGF-1 delivered through a modified fibrin scaffold. , 1998, Growth factors.

[104]  G. Daculsi,et al.  Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: an in vitro study. , 1998, Bone.

[105]  E. Solheim.  Growth factors in bone , 1998, International Orthopaedics.

[106]  J. Glowacki,et al.  Sex steroids, the insulin-like growth factor regulatory system, and aging: implications for the management of older postmenopausal women. , 1998, The journal of nutrition, health & aging.

[107]  K. Leong,et al.  Poly(α-hydroxy acids). Carriers for bone morphogenetic proteins , 1996 .

[108]  P. Deluca,et al.  Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres. , 1995, Journal of pharmaceutical and biomedical analysis.

[109]  H. Oxlund,et al.  Local injection of TGF-β increases the strength of tibial fractures in the rat , 1994 .

[110]  O. Illi,et al.  Biodegradable implant materials in fracture fixation. , 1992, Clinical materials.

[111]  F. Greco,et al.  Fibrin-antibiotic mixtures: an in vitro study assessing the possibility of using a biologic carrier for local drug delivery. , 1991, Journal of biomedical materials research.

[112]  E. Edelman,et al.  Controlled Release of Fibroblast Growth Factor: Activity in Cell Culture , 1991 .

[113]  S. Mohan,et al.  Insulin-like growth factors I and II are present in the skeletal tissues of ten vertebrates. , 1990, Metabolism: clinical and experimental.

[114]  M. Vitiello,et al.  Somatomedin-C levels in healthy young and old men: relationship to peak and 24-hour integrated levels of growth hormone. , 1985, Journal of gerontology.

[115]  G. Stanek,et al.  In vitro properties of mixtures of fibrin seal and antibiotics. , 1983, Biomaterials.